SEC Form 4 · accession 0001556834-15-000005
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joan Winterbottom
Officer — Chief Human Resources Officer
Period of report
Sep 18, 2015
Accepted (ET)
Sep 21, 2015 · 11:16 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.21 | Sep 18, 2015 | P | 20,000 | A | — | Sep 17, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1This option was granted on September 18, 2015 and vests as to 25% of the shares on September 18, 2016, with the remaining 75% of the shares vesting in equal amounts monthly over the three year period commencing on September 18, 2016, provided that the recipient continues to provide services to the Company over such period.